Non disponible en dehors du Royaume-Uni et de l'Irlande
Application
Nimodipine has been used:as a L-type calcium channel (LTCC) inhibitor, to evaluate its neuroprotective activity in the vibrosectionsas a standard, in the enantioseparation of chiral drugs by high performance liquid chromatography (HPLC)in the pharmacological studies for the measurement of spine voltage escape
Biochem/physiol Actions
Nimodipine is a potent L-type Ca2+ channel antagonist.
Nimodipine enhances the survival of dopaminergic substantia nigra neurons.
Caution
Photosensitive
Features and Benefits
This compound was developed by Bayer. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This compound is featured on the Calcium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
Other Notes
Tandem Mass Spectrometry data independently generated by Scripps Center for Metabolomics is available to view or download in PDF. N149.pdf Tested metabolites are featured on Scripps Center for Metabolomics METLIN Metabolite Database. To learn more, visit sigma.com/metlin.
Packaging
100, 500 mg in poly bottle
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :